Article info
PDFAetiology/Harm
Cohort Study
Adverse events associated with mood stabiliser treatment should be continuously monitored in patients diagnosed with bipolar affective disorder
- Correspondence to: Associate Professor René Ernst Nielsen, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark, & Aalborg University Hospital, Department of Psychiatry, Unit for Psychiatric Research, Mølleparkvej 10, Aalborg 9000, Denmark; ren{at}rn.dk
Citation
Adverse events associated with mood stabiliser treatment should be continuously monitored in patients diagnosed with bipolar affective disorder
Publication history
- First published March 2, 2017.
Online issue publication
March 23, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/